Is this you? Create Your Porfile
Avatar

David John Nash

University of California, Berkeley

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where David John Nash is active.

Explore More

Publication

Featured researches published by David John Nash.

Archive | 2002

N-aroyl cyclic amine derivatives as orexin receptor antagonists

Clive Leslie Branch; Wai Ngor GlaxoSmithKline Chan; Amanda GlaxoSmithKline Johns; Christopher Norbert GlaxoSmithKline Johnson; David John Nash; Riccardo Novelli; Jean-Pierre Pilleux; Roderick Alan Porter; Rachel Elizabeth Anne Stead; Geoffrey GlaxoSmithKline Stemp

Archive | 2002

N-aroyl piperazine derivatives as orexin receptor antagonists

Clive Leslie GlawoSmithkline Branch; Christopher Norbert Johson; David John Nash; Geoffrey GlaxoSmithKline Stemp

Archive | 2003

N-aroyl cyclic amines as orexin receptor antagonists

Clive Leslie Branch; Steven Coulton; Amanda SmithKline Beecham Pharm. Johns; David John Nash; Roderick Alan Porter; Geoffrey GlaxoSmithKline Stemp

Archive | 2002

Piperazine bis-amide derivatives and their use as antagonists of the orexin receptor

Clive Leslie Branch; Christopher Norbert GlaxoSmithKline Johnson; David John Nash; Geoffrey GlaxoSmithKline Stemp

Archive | 2006

Piperazine derivatives as glyt1 inhibitors

Daniel Marcus Bradley; Clive Leslie Branch; Bethany Joy Brown; Wai Ngor Chan; Steven Coulton; Anthony William Dean; Paul M. Doyle; Brian L. Evans; Martin Leonard Gilpin; Sharon Lisa GlaxoSmithKline Gough; Jacqueline Anne Macritchie; Howard Marshall; David John Nash; Roderick Alan Porter; Luigi Piero Stasi

Archive | 2006

Acylated piperidines as glycine transporter inhibitors

Daniel Marcus Bradley; Clive Leslie Branch; Wai Ngor GlaxoSmithKline Chan; Steven Coulton; Anthony William Dean; Paul M. Doyle; Brian GlaxoSmithKline Evans; Martin Leonard Gilpin; Sharon Lisa GlaxoSmithKline Gough; Jacqueline Anne Macritchie; Howard Marshall; David John Nash; Roderick Alan Porter; Simon E. Ward

Archive | 2007

N-phenyl-2-0x0-1,4-diazaspir0 [4.5] dec-3-en-1-yl acetamide derivatives and their use as glycine transporter inhibitors

Steven Coulton; Howard Marshall; David John Nash; Roderick Alan Porter

Archive | 2005

COMPOUNDS HAVING MORPHOLINYL AND PIPERIDINYL GROUPS FOR USE AS GLYT1 INHIBITORS

Clive Leslie Branch; David John Nash

Archive | 2007

Compounds which inhibit the glycine transporter and uses thereof

Steven Coulton; Howard Marshall; David John Nash; Roderick Alan Porter

Archive | 2007

1-(2-ARYL-2-OXOETHYL)-3-PHENYL-1, 4-DIAZASPIRO [4.5]DEC-3-EN-2-ONE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORTER INHIBITORS

Clive Leslie Branch; Howard Marshall; David John Nash; Roderick Alan Porter

Explore More

Collaboration

Dive into the David John Nash's collaboration.

Top Co-Authors
Avatar

Roderick Alan Porter

University of California

View shared research outputs
Top Co-Authors
Avatar

Howard Marshall

University of California

View shared research outputs
Top Co-Authors
Avatar

Clive Leslie Branch

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Steven Coulton

University of California

View shared research outputs
Top Co-Authors
Avatar

Geoffrey GlaxoSmithKline Stemp

University of California

View shared research outputs
Top Co-Authors
Avatar

Clive Leslie Branch

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Anthony William Dean

University of California

View shared research outputs
Top Co-Authors
Avatar

Christopher Norbert GlaxoSmithKline Johnson

University of California

View shared research outputs
Top Co-Authors
Avatar

Jacqueline Anne Macritchie

University of California

View shared research outputs
Top Co-Authors
Avatar

Martin Leonard Gilpin

University of California

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge